Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Teladoc Health recently reported its first quarter results for 2024, which provide insights into the company's financial health and strategic directions during its transition period.</li><li>The company is actively seeking a new CEO while focusing on strengthening its market leadership in total care solutions and improving both top and bottom line performance.</li><li>During the first quarter, Teladoc Health surpassed both revenue and adjusted EBITDA expectations set by the company.</li></ul>

Teladoc Health recently reported its first quarter results for 2024, which provide insights into the company's financial health and strategic directions during its transition period.The company is actively seeking a new CEO while focusing on strengthening its market leadership in total care solutions and improving both top and bottom line performance.During the first quarter, Teladoc Health surpassed both revenue and adjusted EBITDA expectations set by the company.

Teladoc Health Inc.: Why Their Expansion of Integrated Care and Chronic Care Programs Is Making Us Bullish? - Major Drivers

<ul><li>Teladoc health has shown growth in the previous year's earnings with an increased focus on operating efficiencies and bottom line performance.</li><li>The company delivered 33% growth in adjusted EBITDA and free cash flow of $194 million in 2023.</li><li>Their selling season yielded double-digit bookings growth over the prior year, with around 75% being upsells or expansions with existing clients.</li></ul>

Teladoc health has shown growth in the previous year's earnings with an increased focus on operating efficiencies and bottom line performance.The company delivered 33% growth in adjusted EBITDA and free cash flow of $194 million in 2023.Their selling season yielded double-digit bookings growth over the prior year, with around 75% being upsells or expansions with existing clients.

Teladoc Health: Performance of Integrated Care and BetterHelp Are Encouraging Factors In 2024 & Beyond! - Major Drivers

<ul><li>Teladoc Health, Inc. delivered mixed results for the previous quarter, with revenues below the analyst consensus.</li><li>The company reported an impressive 8% year-over-year growth in consolidated revenue, reaching $660 million for the third quarter.</li><li>The Integrated Care segment contributed significantly, with a 9% increase in revenue to $374 million.</li></ul>

Teladoc Health, Inc. delivered mixed results for the previous quarter, with revenues below the analyst consensus.The company reported an impressive 8% year-over-year growth in consolidated revenue, reaching $660 million for the third quarter.The Integrated Care segment contributed significantly, with a 9% increase in revenue to $374 million.

Teladoc Health Inc.: The Future of Virtual Care! - Major Drivers

<ul><li>Teladoc managed to exceed analyst expectations in terms of revenue as well as earnings with a robust result, characterized by a 10% YoY growth in consolidated revenue and consolidated adjusted EBITDA exceeding expectations at $72 million.</li><li>Notably, the Integrated Care and BetterHelp segments both performed exceptionally well, with the former seeing 5% YoY revenue growth driven by higher enrollment in the chronic care program.</li><li>BetterHelp, the leading player in mental health services, reported an 18% YoY revenue growth in the second quarter, in line with expectations, emphasizing the sustained demand for mental health services.</li></ul>

Teladoc managed to exceed analyst expectations in terms of revenue as well as earnings with a robust result, characterized by a 10% YoY growth in consolidated revenue and consolidated adjusted EBITDA exceeding expectations at $72 million.Notably, the Integrated Care and BetterHelp segments both performed exceptionally well, with the former seeing 5% YoY revenue growth driven by higher enrollment in the chronic care program.BetterHelp, the leading player in mental health services, reported an 18% YoY revenue growth in the second quarter, in line with expectations, emphasizing the sustained demand for mental health services.

Teladoc Health Inc.: An Expanded Strategic Partnership With Microsoft & Other Major Developments

<ul><li>Teladoc Health managed to surpass the revenue expectations as well as the earnings expectations of Wall Street.</li><li>Consolidated revenue grew by 11% year-over-year, exceeding their guidance range, and their consolidated adjusted EBITDA also exceeded expectations.</li><li>We give Teladoc Health a ‘Hold’ rating with a revised target price.</li></ul>

Teladoc Health managed to surpass the revenue expectations as well as the earnings expectations of Wall Street.Consolidated revenue grew by 11% year-over-year, exceeding their guidance range, and their consolidated adjusted EBITDA also exceeded expectations.We give Teladoc Health a ‘Hold’ rating with a revised target price.

Teladoc Health Inc.: Can It Maintain Its Leadership Position In Digital Healthcare? – Key Drivers

United States

Teladoc Health, Inc. provides healthcare services. The Company diagnoses, recommends treatment, and prescribes medication for routine medical issues through phone and video consultations. Teladoc operates in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Teladoc Health, Inc. (TDOC US)

Teladoc Health Inc.: Why Their Expansion of Integrated Care and Chronic Care Programs Is Making Us Bullish? - Major Drivers

Teladoc Health recently reported its first quarter results for 2024, which provide insights into the company's financial health and strategic...

Baptista Research

Teladoc Health: Performance of Integrated Care and BetterHelp Are Encouraging Factors In 2024 & Beyond! - Major Drivers

Teladoc health has shown growth in the previous year's earnings with an increased focus on operating efficiencies and bottom line performance. The...

Baptista Research

Teladoc Health Inc.: The Future of Virtual Care! - Major Drivers

Teladoc Health, Inc. delivered mixed results for the previous quarter, with revenues below the analyst consensus. The company reported an...

Baptista Research

Teladoc Health Inc.: An Expanded Strategic Partnership With Microsoft & Other Major Developments

Teladoc managed to exceed analyst expectations in terms of revenue as well as earnings with a robust result, characterized by a 10% YoY growth in...

Baptista Research

Teladoc Health Inc.: Can It Maintain Its Leadership Position In Digital Healthcare? – Key Drivers

Teladoc Health managed to surpass the revenue expectations as well as the earnings expectations of Wall Street. Consolidated revenue grew by 11%...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)